Vimal K. Derebail

CureGN-3: UNCPCC

National Institute of Diabetes and Digestive and Kidney Diseases · U01

PI · $2.6M · Univ of North Carolina Chapel Hill

ANCA Glomerulonephritis: From Molecules to Man

National Institute of Diabetes and Digestive and Kidney Diseases · P01

Project lead · $257.1K · Univ of North Carolina Chapel Hill

Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis

Principal investigator · Terminated

University of North Carolina, Chapel Hill

ADPKD Alterations in Hepatic Transporter Function

Principal investigator · Completed

University of North Carolina, Chapel Hill

Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome

Principal investigator · Completed · Phase 1

University of North Carolina, Chapel Hill

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Study director · Completed · Phase 1

University of North Carolina, Chapel Hill